| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |